UPRICHARD DAVID C 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jun 29, 2020
Insider Transaction Report
Form 4
UPRICHARD DAVID C
Director
Transactions
- Award
Stock Option (right to buy)
2020-06-25+5,200→ 5,200 totalExercise: $4.70From: 2021-06-25Exp: 2030-06-25→ Common Stock (5,200 underlying)
Footnotes (1)
- [F1]These options were granted to Dr. U'Prichard for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.